Oligomannan Prebiotic Attenuates Immunological, Clinical and Behavioral Symptoms in Mouse Model of Inflammatory Bowel Disease

Inflammatory bowel disease shows increasing prevalence, however its pathomechanism and treatment is not fully resolved. Prebiotics are non-digestible carbohydrates which might provide an alternative to treat inflammatory conditions in the gut due to their positive effects either on the microbiome or...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferenczi, Szilamér, Szegi, Krisztián, Winkler, Zsuzsanna, Barna, Teréz, Kovács, Krisztina J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034233/
https://www.ncbi.nlm.nih.gov/pubmed/27658624
http://dx.doi.org/10.1038/srep34132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034233/
https://www.ncbi.nlm.nih.gov/pubmed/27658624
http://dx.doi.org/10.1038/srep34132

Ejemplares similares